Back
Apellis Pharmaceuticals Stock Price Chart
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16
APLS
Apellis Pharmaceuticals
Last Price:
$17.49
Seasonality Move:
-1%
7 Day Trial
ALL ACCESS PASS
$
7
Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.14 | Sell |
| 20-day SMA: | 20 | Sell |
| 50-day SMA: | 23.54 | Sell |
| 200-day SMA: | 30.65 | Sell |
| 8-day EMA: | 18.14 | Sell |
| 20-day EMA: | 19.79 | Sell |
| 50-day EMA: | 22.91 | Sell |
| 200-day EMA: | 31.14 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.85 | Sell |
| Relative Strength Index (14 RSI): | 27 | Sell |
| Chaikin Money Flow: | -437828 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.25 - 23.35) | Sell |
| Bollinger Bands (100): | (22.63 - 32.81) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 17.54 while APLS 8-day simple moving average is 18.14, which is a Sell signal.
-
The stock price of APLS is 17.54 while Apellis Pharmaceuticals 20-day SMA is 20.00, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day simple moving average is 23.54 while APLS share price is 17.54, making it a Sell technically.
-
APLS stock price is 17.54 and Apellis Pharmaceuticals 200-day simple moving average is 30.65, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
16
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $17.54. The Score for APLS is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
2.2B
Price in USD:
17.54
Share Volume:
1.8M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
50.98
52-Week Low:
17.02
Sell
16
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 17.54 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 17.54 while APLS 8-day exponential moving average is 18.14, which is a Sell signal.
-
The stock price of APLS is 17.54 while Apellis Pharmaceuticals 20-day EMA is 19.79, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day exponential moving average is 22.91 while APLS share price is 17.54, making it a Sell technically.
-
APLS stock price is 17.54 and Apellis Pharmaceuticals 200-day simple moving average is 31.14, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.03 per share, an increase this year of $0.70 per share, and an increase next year of $1.02 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is -1.85, suggesting Apellis Pharmaceuticals is a Sell
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 27, which suggest Apellis Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (18.25 - 23.35), which suggest Apellis Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (22.63 - 32.81), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.